Impairment of fetal hematopoietic stem cell function in the absence of Fancd2.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27915139)

Published in Exp Hematol on November 30, 2016

Authors

Sakiko Suzuki1, Ronny R Racine1, Nathan A Manalo1, Sharon B Cantor2, Glen D Raffel3

Author Affiliations

1: Division of Hematology-Oncology, University of Massachusetts Medical School, Worcester, MA, USA.
2: Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Medical School, Worcester, MA, USA.
3: Division of Hematology-Oncology, University of Massachusetts Medical School, Worcester, MA, USA. Electronic address: glen.raffel@umassmed.edu.

Articles cited by this

Telomere dysfunction induces metabolic and mitochondrial compromise. Nature (2011) 6.36

Fancd2 counteracts the toxic effects of naturally produced aldehydes in mice. Nature (2011) 3.79

Molecular pathogenesis of Fanconi anemia: recent progress. Blood (2006) 3.76

Epithelial cancer in Fanconi anemia complementation group D2 (Fancd2) knockout mice. Genes Dev (2003) 3.58

Genotoxic consequences of endogenous aldehydes on mouse haematopoietic stem cell function. Nature (2012) 3.34

Bone marrow failure in Fanconi anemia is triggered by an exacerbated p53/p21 DNA damage response that impairs hematopoietic stem and progenitor cells. Cell Stem Cell (2012) 2.26

Maternal aldehyde elimination during pregnancy preserves the fetal genome. Mol Cell (2014) 2.24

Loss of FancC function results in decreased hematopoietic stem cell repopulating ability. Blood (1999) 2.00

Stem cell collection and gene transfer in Fanconi anemia. Mol Ther (2007) 1.81

Real-time PCR assay for measurement of mouse telomeres. Comp Med (2006) 1.80

Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1. Stem Cells (2010) 1.60

Why does the bone marrow fail in Fanconi anemia? Blood (2013) 1.55

Senescence and apoptosis block hematopoietic activation of quiescent hematopoietic stem cells with short telomeres. Blood (2014) 1.46

Fancd2-/- mice have hematopoietic defects that can be partially corrected by resveratrol. Blood (2010) 1.29

Accelerated telomere shortening and telomerase activation in Fanconi's anaemia. Br J Haematol (1999) 1.26

A role for monoubiquitinated FANCD2 at telomeres in ALT cells. Nucleic Acids Res (2009) 1.24

Characterization of mouse hematopoietic stem and progenitor cells. Curr Protoc Immunol (2008) 1.21

The p53 pathway in hematopoiesis: lessons from mouse models, implications for humans. Blood (2012) 1.16

Hematopoietic compartment of Fanconi anemia group C null mice contains fewer lineage-negative CD34+ primitive hematopoietic cells and shows reduced reconstruction ability. Exp Hematol (1999) 1.14

Differential homing and engraftment properties of hematopoietic progenitor cells from murine bone marrow, mobilized peripheral blood, and fetal liver. Blood (2001) 1.14

Genomic characterization of the inherited bone marrow failure syndromes. Semin Hematol (2013) 1.07

HPV-16 E7 reveals a link between DNA replication stress, fanconi anemia D2 protein, and alternative lengthening of telomere-associated promyelocytic leukemia bodies. Cancer Res (2008) 1.07

The Fanconi anaemia pathway: new players and new functions. Nat Rev Mol Cell Biol (2016) 1.07

Learning from a paradox: recent insights into Fanconi anaemia through studying mouse models. Dis Model Mech (2013) 1.05

Fetal origins of hematopoietic failure in a murine model of Fanconi anemia. Blood (2013) 0.98

Genetic disruption of both Fancc and Fancg in mice recapitulates the hematopoietic manifestations of Fanconi anemia. Blood (2010) 0.95

Hematopoietic stem cells lacking Ott1 display aspects associated with aging and are unable to maintain quiescence during proliferative stress. Blood (2012) 0.93

p53-Independent apoptosis disrupts early organogenesis in embryos lacking both ataxia-telangiectasia mutated and Prkdc. Mol Cancer Res (2006) 0.86

TGF-β Inhibition Rescues Hematopoietic Stem Cell Defects and Bone Marrow Failure in Fanconi Anemia. Cell Stem Cell (2016) 0.84

Neonatal manifestations of inherited bone marrow failure syndromes. Semin Fetal Neonatal Med (2015) 0.77